HRS7415

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRS7415, covering 2026-03-13 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HRS7415 Tablets in Patients With Advanced Malignant Tumors [Phase 1]